Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating Profit | $49.48M | $41.47M | $42.58M | $54.01M | $54.18M |
| Net Profit | $108.57M | $22.29M | $30.91M | $26.78M | $27.16M |
| Selling and Admin Expenses | $158.13M | $143.57M | $143.37M | $138.52M | $137.78M |
| Net Income to Parent Company | $108.57M | $22.29M | $30.91M | $26.78M | $27.16M |
| Basic EPS | $1.98 | $0.41 | $0.57 | $0.49 | $0.50 |
| Diluted EPS | $1.93 | $0.40 | $0.56 | $0.49 | $0.50 |
| Operating Expense | $224.19M | $202.28M | $197.20M | $190.84M | $184.81M |
| Gross Profit | $273.67M | $243.75M | $239.77M | $244.86M | $238.99M |
| Cost of Revenue | $116.92M | $118.51M | $121.15M | $112.90M | $113.54M |
| Total Operating Revenue | $390.59M | $362.26M | $360.92M | $357.75M | $352.52M |
| Earnings from Equity Interest Net of Tax | -$114,000.00 | -$851,000.00 | -$10,000.00 | -$13,000.00 | -$8,000.00 |
| Tax | -$90.20M | $4.34M | -$3.28M | $7.11M | $6.15M |
| Pretax Profit | $18.48M | $27.49M | $27.63M | $33.91M | $33.32M |
| Net Non-Operating Interest Income (Expense) | -$3.35M | -$4.74M | -$6.40M | -$6.96M | -$10.75M |
| Non-Operating Interest Income | $3.83M | $3.55M | $4.46M | $3.90M | $4.18M |
| Non-Operating Interest Expense | $7.18M | $8.29M | $10.86M | $10.86M | $14.93M |
| Other Operating Expenses | $12.40M | $15,000.00 | $1.71M | $3.74M | -$160,000.00 |
| Other Income (Expense) | -$27.66M | -$9.25M | -$8.54M | -$13.14M | -$10.12M |
| Special Income (Charges) | $13.65M | -$1.13M | $2.39M | -$2.86M | -$1.68M |
| Research & Development | $53.66M | $58.70M | $52.12M | $48.58M | $47.19M |
| -Gain on Sale of Property/Plant/Equipment | $13.65M | – | – | – | $0.00 |
| Other Non-Operating Income (Expenses) | $105,000.00 | – | – | – | $200,000.00 |
| Total Revenue as Reported | $390.59M | $362.26M | $360.92M | $357.75M | $352.52M |
| Profit from Continuing Operations | $108.57M | $22.29M | $30.91M | $26.78M | $27.16M |
| -Less:Write Off | $0.00 | $1.13M | $0.00 | $1.11M | $0.00 |
| Net Income to Common Stockholders | $108.57M | $22.29M | $30.91M | $26.78M | $27.16M |
| Gain on Sale of Security | -$41.41M | -$8.12M | -$11.60M | -$10.28M | -$8.64M |
| -Less:Other Special Charges | – | – | $1.74M | $1.75M | $1.68M |
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Net cash flow from continuing operations | $254.34M | $183.04M | $74.91M | $69.92M | $102.54M |
| -Change In Other Working Capital | -$1.09M | $2.28M | -$19.13M | -$6.56M | $3.26M |
| -Change in Other Current Liabilities | $365.55M | $0.00 | $0.00 | – | – |
| -Change in Other Current Assets | $38.54M | -$1.65M | $15.30M | $7.49M | $24.13M |
| -Change in Payables and Accrued Expense | -$17.04M | -$3.63M | $26.55M | -$2.13M | $13.10M |
| -Change in Inventory | -$5.29M | -$6.76M | -$28.48M | -$25.68M | $4.48M |
| -Change in Receivables | -$10.71M | $11.06M | -$28.86M | -$4.81M | -$15.75M |
| Change in Working Capital | $369.97M | $1.31M | -$34.62M | -$31.69M | $29.22M |
| Other Non-Cash Items | $34.10M | $27.87M | $29.52M | -$6.89M | $17.94M |
| Deferred Tax | $455,000.00 | $6.80M | -$114.43M | $1.41M | $2.85M |
| Depreciation & Depletion & Amortization | $59.63M | $51.14M | $60.86M | $57.80M | $67.99M |
| Gain/Loss from Continuing Operations | -$8.38M | $137,000.00 | -$22.91M | -$38.66M | $77.86M |
| Net Income from Continuing Operations | -$242.47M | $63.23M | $17.55M | -$86.25M | -$135.82M |
| Net cash flow from investing | -$72.91M | -$48.16M | -$40.33M | -$38.41M | $36.90M |
| Net Cash Flow from Continuing Investing Activities | -$72.91M | -$48.16M | -$40.33M | -$38.41M | $36.90M |
| Net Investment Purchase and Sale | $857,000.00 | -$1.14M | -$6.50M | -$2.95M | $19.40M |
| Net PPE Purchase and Sale | -$81.05M | -$47.11M | -$34.98M | -$26.52M | -$25.48M |
| Free Cash Flow | $173.29M | $135.93M | $39.93M | $43.40M | $77.07M |
| Operating Cash Flow | $254.34M | $183.04M | $74.91M | $69.92M | $102.54M |
| Effect of Exchange Rate Changes | $16.23M | -$7.75M | $6.19M | -$4.01M | -$2.81M |
| Beginning Cash Balance | $723.56M | $577.87M | $515.62M | $207.99M | $252.83M |
| Net Change in Cash | -$104.23M | $153.43M | $56.07M | $311.64M | -$42.04M |
| Ending Cash Balance | $635.55M | $723.56M | $577.87M | $515.62M | $207.99M |
| Net Other Financing Charges | -$338,000.00 | -$67.32M | $592,000.00 | $4.15M | -$16.19M |
| Proceeds from Stock Option Exercised | -$4.40M | -$2.10M | -$7.48M | -$8.03M | – |
| Net Issuance Payments Of Debt | -$280.93M | $87.97M | $28.38M | $284.01M | -$487.85M |
| Net Cash Flow from Continuing Financing Activities | -$285.66M | $18.55M | $21.48M | $280.13M | -$181.48M |
| Financing Cash Flow | -$285.66M | $18.55M | $21.48M | $280.13M | -$181.48M |
| Net Other Investing Changes | $7.28M | $89,000.00 | $1.15M | -$88,000.00 | $1.73M |
| Net Business Purchase and Sale | – | – | – | -$8.86M | $41.25M |
| Net Common Stock Issuance | – | – | – | – | $322.56M |
No comments yet — be the first to weigh in on LIVN.